$4 billion price tag? FDA's proposed generic drug labelling rule
By EsqSocial Corporation 14/03/14
An economic consulting group recently published findings that a Food and Drug Administration (FDA) proposed rule will increase annual healthcare costs by $4 billion. The FDA's proposal, announced in November 2013, will allow generic drug...
By: Morrison & Foerster LLP